The Beauty Health Company
SKIN
$1.76
-$0.11-5.88%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 334.29M | 347.62M | 366.23M | 393.12M | 397.99M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 334.29M | 347.62M | 366.23M | 393.12M | 397.99M |
Cost of Revenue | 152.00M | 171.98M | 243.80M | 243.75M | 242.88M |
Gross Profit | 182.30M | 175.64M | 122.43M | 149.37M | 155.11M |
SG&A Expenses | 243.77M | 246.49M | 253.15M | 269.40M | 275.93M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 402.07M | 426.60M | 505.79M | 523.71M | 528.91M |
Operating Income | -67.77M | -78.98M | -139.56M | -130.60M | -130.92M |
Income Before Tax | -29.55M | -26.63M | -80.63M | -79.31M | -101.89M |
Income Tax Expenses | -452.00K | 1.54M | 3.07M | 1.23M | -1.77M |
Earnings from Continuing Operations | -29.10 | -28.17 | -83.70 | -80.54 | -100.12 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -29.10M | -28.17M | -83.70M | -80.54M | -100.12M |
EBIT | -67.77M | -78.98M | -139.56M | -130.60M | -130.92M |
EBITDA | -34.09M | -41.88M | -104.04M | -93.53M | -96.24M |
EPS Basic | -0.23 | -0.22 | -0.63 | -0.61 | -0.76 |
Normalized Basic EPS | -0.24 | -0.22 | -0.49 | -0.40 | -0.50 |
EPS Diluted | -0.43 | -0.42 | -0.83 | -0.71 | -0.76 |
Normalized Diluted EPS | -0.22 | -0.21 | -0.48 | -0.40 | -0.50 |
Average Basic Shares Outstanding | 495.30M | 499.61M | 508.45M | 517.45M | 526.75M |
Average Diluted Shares Outstanding | 534.86M | 539.18M | 548.02M | 538.81M | 526.75M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |